I think Scott believes No News is Good News i only because my patience has expired with Mr Richards. Hopefully the Board has been looking very closely . Although it appea he is Chairman’s Golden Boy. with Anti Competitive Laws being enforced last 25 yrs price paid for Teva pipeline was obviously far too high. As has been verified by recent writedowns. CEO would have been well aware of this fact.(if not should have). my investment similar to KP. Hands tied. IMO Scott is a Salesman.(that ’s Ok) But has been buying business whether it be Teva . Lexette Good product great market share Cost $32m ! Exclusivity ceases 20 mnths May 2021. Efudex $30 m i agree he can value add from extra sales exist staff. Just as well. Ansett staff were happiest best pay and conditions.(?????) more recently TFS $2.21/ share 1/2 m+ shares similar size Mayne. Popular CEO surrounded by overpaid non productive friends and Best Boss ever had attitude heavily shorted by Glaucus. now Quintis. shareholders lost everything. CEO over 17 did very well. Not saying Scott is the same but Enough Nearly $3m and some Adelaide Administration staff much too highly rewarded. ii agree with most your comments Simmp Cant Agree Mr Richards Too much verbal D.
MYX Price at posting:
52.0¢ Sentiment: Buy Disclosure: Held
